Boyce & Associates Wealth Consulting’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $235K | Buy |
1,264
+11
| +0.9% | +$2.04K | 0.21% | 66 |
|
|
2025
Q1 | $263K | Buy |
1,253
+1
| +0.1% | +$210 | 0.26% | 57 |
|
|
2024
Q4 | $222K | Buy |
1,252
+1
| +0.1% | +$178 | 0.23% | 66 |
|
|
2024
Q3 | $247K | Buy |
1,251
+2
| +0.2% | +$395 | 0.26% | 64 |
|
|
2024
Q2 | $214K | Buy |
1,249
+1
| +0.1% | +$172 | 0.25% | 64 |
|
|
2024
Q1 | $227K | Buy |
+1,248
| New | +$227K | 0.29% | 53 |
|
|
2023
Q2 | – | Sell |
-1,274
| Closed | -$206K | – | 49 |
|
|
2023
Q1 | $206K | Buy |
1,274
+34
| +3% | +$5.49K | 0.37% | 47 |
|
|
2022
Q4 | $200K | Buy |
+1,240
| New | +$200K | 0.38% | 44 |
|
|
2022
Q2 | – | Sell |
-1,236
| Closed | -$200K | – | 48 |
|
|
2022
Q1 | $200K | Buy |
+1,236
| New | +$200K | 0.3% | 51 |
|